Built for U.S. Generic Manufacturers
Commercial intelligence, without the spreadsheets
Track approvals, new entrants, pricing pressure, manufacturing exposure, and competitor activity in one place. Your team gets to portfolio and commercial decisions faster.
Unified across the data sources you already trust
Your market signals are public. Your synthesis workflow is the bottleneck.
Generic manufacturers already have access to regulatory filings, pricing feeds, and market data. The problem is turning those scattered sources into timely commercial decisions.
Weekly review decks lag behind the market. By the time signals reach decision-makers, competitors have already moved.
Approvals in one tab, pricing in a spreadsheet, manufacturing risk in an email chain. No single view ties them together.
Seeing the data is not the problem. The gap is knowing what changed, why it matters, and what to do next.
Explore the platform
One workspace for molecule, company & market intelligence
Rx Pulse delivers actionable prescription market analytics, competitive intelligence, and commercialization insights for pharmaceutical organizations entering or scaling in the US market. Search any molecule or manufacturer and the full commercial picture loads in seconds. Scroll down to see it in action.
Product Intelligence
Every signal on a molecule, in a single view
Search a molecule and the whole picture is right there: market size, competitor share, growth trends, pricing, and where it's made. No tab-hopping, no stitching spreadsheets together.
- Market size, competitor share & quarterly growth trend
- Branded reference, approved strengths & exclusivity status
- Global manufacturing & supply-chain site map
- VA government contracts & NADAC pricing
Organization Intelligence
Size up any competitor's whole portfolio
Search a manufacturer and you get the full company picture at a glance: total revenue, active portfolio, top products, quarterly performance, competitor overlap, and their global manufacturing footprint.
- Portfolio revenue, market size & active approved products
- Top products by revenue & 80/20 Pareto view
- Competitor overlap & volume-based market share
- Quarterly performance trends & manufacturing sites
FDA Alerts
Catch every regulatory move as it happens
A rolling feed of the events that move generic markets: new approvals, inspections, exclusivity expiries, and shortages. Each one comes with the site, volume, and pricing context you need to act on it. Switch tabs to preview each feed.
- New ANDA, NDA & BLA approvals (first-generic flagged)
- Form 483 inspections with site & volume context
- Exclusivity expiries, both expired and expiring soon
- Drug shortages with affected NDCs & volume exposure
- Real-time alerts Coming soon
Questions your team can answer in seconds
Ready to replace your spreadsheets?
Search any molecule above to see the full product intelligence view. Organization intelligence and alerts are available from the top navigation.